Arthur Holanda Dantas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arthur Holanda Dantas has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- André Costa Teixeira
Hospital Geral de Fortaleza
2 shared publications - Beatriz de Oliveira Neri
Hospital Geral de Fortaleza
2 shared publications - Ronaldo de Matos Esmeraldo
Hospital Geral de Fortaleza
2 shared publications - Sabrina Maria Araujo Sobreira
Hospital Geral de Fortaleza
2 shared publications - Sebastiao Alves Sobreira Neto
Hospital Geral de Fortaleza
2 shared publications - Vanessa Gurgel Adeodato
Hospital Geral de Fortaleza
2 shared publications
Latest Publications
- 28 April 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
Diagnóstico Tardio de Hiperoxalúria Primária Tipo 1 Após Transplante Renal
A hiperoxalúria primária do tipo 1 é uma causa rara e frequentemente não reconhecida de disfunção e perda do enxerto renal, sobretudo quando a doença renal é atribuída à nefrolitíase recorrente. Relata-se o caso de uma mulher de 62 anos, com história de litíase bilateral e uso prolongado de anti-inflamatórios, submetida a transplante renal com função imediata e evolução inicial favorável. Após período prolongado de estabilidade, ocorreu disfunção tardia e progressiva do enxerto. A biópsia do enxerto demonstrou lesão tubular associada a depósitos intensos de cristais de oxalato de cálcio, sugerindo oxalose. A pesquisa do oxalato sérico foi de 18,6 μmol/L, e o urinário, de 94,9 mg/24 h. Estudo de genotipagem identificou variante patogênica em homozigose no gene AGXT, confirmando diagnóstico de hiperoxalúria primária tipo 1. A revisão da história médica evidenciou nefrocalcinose em rins nativos, e o rastreamento familiar permitiu identificar um irmão com nefrolitíase. Instituiu-se piridoxina em dose farmacológica como primeira linha terapêutica, com base no genótipo responsivo, seguida de terapia de interferência de RNA com lumasiran, diante do alto risco ao enxerto, com estabilização inicial da função do órgão transplantado. Este relato reforça que a hiperoxalúria primária do tipo 1 deve ser considerada em receptores com histórico de nefrolitíase, mesmo em idade adulta, e que a identificação pós-transplante tem implicações diretas no prognóstico do enxerto, na abordagem terapêutica e no rastreamento familiar, destacando a necessidade de investigação metabólica e genética em casos selecionados antes do transplante.
- 28 April 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
Diagnóstico Tardio de Hiperoxalúria Primária Tipo 1 Após Transplante Renal
A hiperoxalúria primária do tipo 1 é uma causa rara e frequentemente não reconhecida de disfunção e perda do enxerto renal, sobretudo quando a doença renal é atribuída à nefrolitíase recorrente. Relata-se o caso de uma mulher de 62 anos, com história de litíase bilateral e uso prolongado de anti-inflamatórios, submetida a transplante renal com função imediata e evolução inicial favorável. Após período prolongado de estabilidade, ocorreu disfunção tardia e progressiva do enxerto. A biópsia do enxerto demonstrou lesão tubular associada a depósitos intensos de cristais de oxalato de cálcio, sugerindo oxalose. A pesquisa do oxalato sérico foi de 18,6 μmol/L, e o urinário, de 94,9 mg/24 h. Estudo de genotipagem identificou variante patogênica em homozigose no gene AGXT, confirmando diagnóstico de hiperoxalúria primária tipo 1. A revisão da história médica evidenciou nefrocalcinose em rins nativos, e o rastreamento familiar permitiu identificar um irmão com nefrolitíase. Instituiu-se piridoxina em dose farmacológica como primeira linha terapêutica, com base no genótipo responsivo, seguida de terapia de interferência de RNA com lumasiran, diante do alto risco ao enxerto, com estabilização inicial da função do órgão transplantado. Este relato reforça que a hiperoxalúria primária do tipo 1 deve ser considerada em receptores com histórico de nefrolitíase, mesmo em idade adulta, e que a identificação pós-transplante tem implicações diretas no prognóstico do enxerto, na abordagem terapêutica e no rastreamento familiar, destacando a necessidade de investigação metabólica e genética em casos selecionados antes do transplante.
- Open Access
- 28 April 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
Late Diagnosis of Primary Hyperoxaluria Type 1 After Kidney Transplant
Primary hyperoxaluria type 1 is a rare and often unrecognized cause of renal allograft dysfunction and loss, particularly when renal disease is attributed to recurrent nephrolithiasis. We report the case of a 62-year-old woman with a history of bilateral nephrolithiasis and prolonged use of anti-inflammatory drugs who underwent kidney transplantation with immediate graft function and an initially favorable course. After an extended period of stability, late and progressive graft dysfunction occurred. Allograft biopsy demonstrated tubular injury associated with extensive calcium oxalate crystal deposition, suggesting oxalosis. Serum oxalate was 18.6 µmol/L, and urinary oxalate was 94.9 mg/24 h. Genotyping identified a homozygous pathogenic variant in the AGXT gene, confirming the diagnosis of primary hyperoxaluria type 1. Review of the medical history revealed nephrocalcinosis in native kidneys, and family screening identified a sibling with nephrolithiasis. Pharmacological-dose pyridoxine was initiated as first-line therapy based on the responsive genotype, followed by RNA interference therapy with lumasiran due to the high risk of graft loss, resulting in initial stabilization of graft function. This report emphasizes that primary hyperoxaluria type 1 should be considered in transplant recipients with a history of nephrolithiasis, even in adulthood, and that post-transplant identification has direct implications for graft prognosis, therapeutic approach, and family screening, highlighting the need for metabolic and genetic investigation in selected cases before transplantation.
- 28 April 2026
- Published by Associacao Brasileira de Transplantes de Orgaos in Brazilian Journal of Transplantation
Open AccessLate Diagnosis of Primary Hyperoxaluria Type 1 After Kidney Transplant
Primary hyperoxaluria type 1 is a rare and often unrecognized cause of renal allograft dysfunction and loss, particularly when renal disease is attributed to recurrent nephrolithiasis. We report the case of a 62-year-old woman with a history of bilateral nephrolithiasis and prolonged use of anti-inflammatory drugs who underwent kidney transplantation with immediate graft function and an initially favorable course. After an extended period of stability, late and progressive graft dysfunction occurred. Allograft biopsy demonstrated tubular injury associated with extensive calcium oxalate crystal deposition, suggesting oxalosis. Serum oxalate was 18.6 µmol/L, and urinary oxalate was 94.9 mg/24 h. Genotyping identified a homozygous pathogenic variant in the AGXT gene, confirming the diagnosis of primary hyperoxaluria type 1. Review of the medical history revealed nephrocalcinosis in native kidneys, and family screening identified a sibling with nephrolithiasis. Pharmacological-dose pyridoxine was initiated as first-line therapy based on the responsive genotype, followed by RNA interference therapy with lumasiran due to the high risk of graft loss, resulting in initial stabilization of graft function. This report emphasizes that primary hyperoxaluria type 1 should be considered in transplant recipients with a history of nephrolithiasis, even in adulthood, and that post-transplant identification has direct implications for graft prognosis, therapeutic approach, and family screening, highlighting the need for metabolic and genetic investigation in selected cases before transplantation.
- Open Access
- 6 May 2024
- Published by Revista Latino-Americana de Marcapasso e Arritmia in JOURNAL OF CARDIAC ARRHYTHMIAS
- Vol. 37
What are the characteristics and results of Tilt Tests in the elderly?
Introduction: The elderly have several causes of syncope or pre-syncope. The importance of the Tilt Test (TT) has been questioned in this population. However, dysautonomic causes are common in these age groups, having an impact on morbidity and mortality. Objective: Compare the results of the TT between the age groups of the elderly (>=60 years) and the non-elderly. Methods: Crosssectional study carried out between 2016-2021. We used the Mann-Whitney and Chi-square tests, with a p-value < 5% considered significant. The protocols used were Westminster or Italian. Results: We analyzed 2364 tilt tests, 61.7% female, aged 51.1 (31-71) years. Positivity was 32.6%, 37.2% with sensitization (p < 0.0001). In the elderly group (EG), there were 958 tests (40.5%) and 1381 (58.4%) in the non-elderly (NEG). EG positivity was 270 (28.0%), lower than NEG with 524 (37.43%) (p < 0.01). Positivity with sensitization in EG was 195 (20.35%) x 403(29.18%) in NEG (p<0.001). In EG, 50 patients (5.22%) had a dysautonomic response and in NEG, there were 10 (0.72%) (p < 0.001). Complications were 4.2% EG x 2.6% NEG ( p= 0.03). Conclusion: The TT in the elderly showed a lower incidence of positivity in the passive and sensitization phases compared to the non-elderly. Vasovagal causes were the most frequent causes in the elderly, had a higher incidence of dysautonomic responses, fewer prodromes and a higher rate of complications, however without severity.
- 6 May 2024
- Published by Revista Latino-Americana de Marcapasso e Arritmia in JOURNAL OF CARDIAC ARRHYTHMIAS
- Vol. 37
Open AccessWhat are the characteristics and results of Tilt Tests in the elderly?
Introduction: The elderly have several causes of syncope or pre-syncope. The importance of the Tilt Test (TT) has been questioned in this population. However, dysautonomic causes are common in these age groups, having an impact on morbidity and mortality. Objective: Compare the results of the TT between the age groups of the elderly (>=60 years) and the non-elderly. Methods: Crosssectional study carried out between 2016-2021. We used the Mann-Whitney and Chi-square tests, with a p-value < 5% considered significant. The protocols used were Westminster or Italian. Results: We analyzed 2364 tilt tests, 61.7% female, aged 51.1 (31-71) years. Positivity was 32.6%, 37.2% with sensitization (p < 0.0001). In the elderly group (EG), there were 958 tests (40.5%) and 1381 (58.4%) in the non-elderly (NEG). EG positivity was 270 (28.0%), lower than NEG with 524 (37.43%) (p < 0.01). Positivity with sensitization in EG was 195 (20.35%) x 403(29.18%) in NEG (p<0.001). In EG, 50 patients (5.22%) had a dysautonomic response and in NEG, there were 10 (0.72%) (p < 0.001). Complications were 4.2% EG x 2.6% NEG ( p= 0.03). Conclusion: The TT in the elderly showed a lower incidence of positivity in the passive and sensitization phases compared to the non-elderly. Vasovagal causes were the most frequent causes in the elderly, had a higher incidence of dysautonomic responses, fewer prodromes and a higher rate of complications, however without severity.